Across TCGA pan-cancer cohorts, H2ACP2 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated H2ACP2 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher H2ACP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated H2ACP2 expression acts as an unfavorable survival marker, although some lineages such as LUSC and UCS show a favorable association.
ACC, MESO, and SKCM are the cancer types where H2ACP2 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.